Loading chat...
OK SR57
Resolution
AI Summary
- Approximately 1,000 to 1,200 cases of meningococcal disease occur annually in the U.S., with 10 to 15 percent mortality rate and 11 to 19 percent of survivors experiencing serious side effects including limb loss and nervous system damage
- Young adults ages 16 to 21 are among the most commonly affected, with serogroups B, C, and Y accounting for most U.S. cases; recent outbreaks of serogroup B meningitis have occurred on college campuses resulting in deaths
- Vaccines are available to protect against all three common serogroups, with CDC routinely recommending vaccination for serogroups A, C, W, and Y; decisions to vaccinate ages 16 to 23 against serogroup B should be made individually with health care providers
- Oklahoma State Senate expresses its wish to raise awareness of vaccinations' critical role in preventing meningococcal disease
- Oklahoma State Senate encourages all high school and college age students and their parents to educate themselves about disease serogroups, symptoms, risks, and treatment options
Legislative Description
A resolution raising awareness of the importance of vaccinations in preventing meningococcal disease; and encouraging high school and college age students and their parents to educate themselves about the devastating illness.
Last Action
Enrolled, filed with Secretary of State
5/18/2016
Full Bill Text
No bill text available